J Breast Cancer.  2011 Mar;14(1):72-75. 10.4048/jbc.2011.14.1.72.

Microglandular Adenosis

Affiliations
  • 1Department of Surgery, Chungbuk National University, College of Medicine and Medical Research Institute, Cheongju, Korea. yjsong@chungbuk.ac.kr

Abstract

Microglandular adenosis (MGA) of the breast is a very rare and benign proliferative lesion. Most patients complain of a palpable breast mass that may arouse a clinical suspicion of breast cancer. Histopathologically, it is hard to distinguish MGA from breast cancer because of the lack of a myoepithelial layer and infiltrative proliferation. Several studies have reported a strong relationship between MGA and carcinoma arising in MGA, so the mass should be excised completely in cases of MGA determined from a core needle biopsy rather than observation. A 72-years-old woman presented with a palpable breast mass. On physical examination, a mass was palpable in the right upper outer quadrant area and somewhat fixed to the surrounding tissues and pectoralis major muscle. We could not detect any mass or dense lesion on mammography because of a grade 4 dense breast. Ultrasonographic findings revealed a low echoic lesion with indistinct margins. The result of a core needle biopsy was MGA, which was confirmed by excision. We report one case of MGA, which was believed to breast cancer clinically.

Keyword

Breast; Cancer; Microglandular adenosis

MeSH Terms

Biopsy, Large-Core Needle
Breast
Breast Neoplasms
Female
Fibrocystic Breast Disease
Humans
Mammography
Muscles
Physical Examination

Figure

  • Figure 1 Ultrasonographic finding of microglandular adenosis. Ill-defined low echoic lesion (BIRADS category 5) in the upper outer quadrant of right breast was shown in ultrasonogram.

  • Figure 2 Gross appearance of microglandular adenosis (MGA). This is a gross appearance of MGA. Hematoma in the mass is result of the previous needle biopsy.

  • Figure 3 Microscopic finding of microglandular adenosis (MGA). Infiltrating round glands lacking a myoepithelial layer are seen with luminal eosinophilic secrestions. The glands are regular and small, and are lined by single epithelial layer (H&E stain, ×40).

  • Figure 4 Immunohistochemistry (IHC) of microglandular adenosis (MGA). IHC of MGA shows positive for S-100 protein (IHC stain, ×40).

  • Figure 5 Immunohistochemistry (IHC) of microglandular adenosis (MGA). IHC of MGA shows positive for pan-cytokeratin (IHC stain, ×400).

  • Figure 6 Immunohistochemistry (IHC) of microglandular adenosis (MGA). IHC of MGA shows negative for SMA (IHC stain, ×400).


Reference

1. McDivitt RW, Stewart FW, Berg JW. Armed Forces Institute of Pathology (U.S.). Universities Associated for Research and Education in Pathology. Tumors of the breast. Atlas of Tumor Pathology, Second Serise, Fascicle 2. 1968. Wathington, D.C.: Armed Forces Institute of Pathology;91.
2. Rosen PP. Rosen's Breast Pathology. 2009. 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins;175–186.
3. Rosen PP. Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma. Am J Surg Pathol. 1983. 7:137–144.
4. Geyer FC, Kushner YB, Lambros MB, Natrajan R, Mackay A, Tamber N, et al. Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma. Histopathology. 2009. 55:732–743.
Article
5. Eusebi V, Foschini MP, Betts CM, Gherardi G, Millis RR, Bussolati G, et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison. Am J Surg Pathol. 1993. 17:99–109.
Article
6. Popper HH, Gallagher JV, Ralph G, Lenard PD, Tavassoli FA. Breast carcinoma arising in microglandular adenosis: a tumor expressing S-100 immunoreactivity. Report of five cases. Breast J. 1996. 2:154–159.
Article
7. Tavassoli FA, Bratthauer GL. Immunohistochemical profile and differential diagnosis of microglandular adenosis. Mod Pathol. 1993. 6:318–322.
8. James BA, Cranor ML, Rosen PP. Carcinoma of the breast arising in microglandular adenosis. Am J Clin Pathol. 1993. 100:507–513.
Article
9. Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, et al. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Am J Surg Pathol. 2009. 33:496–504.
Article
10. Diaz NM, McDivitt RW, Wick MR. Microglandular adenosis of the breast. An immunohistochemical comparison with tubular carcinoma. Arch Pathol Lab Med. 1991. 115:578–582.
11. Koenig C, Dadmanesh F, Bratthauer GL, Tavassoli FA. Carcinoma arising in microglandular adenosis: an immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol. 2000. 8:303–315.
Article
12. Acs G, Simpson JF, Bleiweiss IJ, Hugh J, Reynolds C, Olson S, et al. Microglandular adenosis with transition into adenoid cystic carcinoma of the breast. Am J Surg Pathol. 2003. 27:1052–1060.
Article
13. Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, et al. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol. 2008. 32:544–552.
Article
14. Resetkova E, Flanders DJ, Rosen PP. Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation. Arch Pathol Lab Med. 2003. 127:77–80.
Article
15. Salarieh A, Sneige N. Breast carcinoma arising in microglandular adenosis: a review of the literature. Arch Pathol Lab Med. 2007. 131:1397–1399.
Article
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr